Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("TSIMELZON, Anna")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 26

  • Page / 2
Export

Selection :

  • and

Radical [n + 1] annulations with sulfur dioxideTSIMELZON, Anna; BRASLAU, Rebecca.Journal of organic chemistry. 2005, Vol 70, Num 26, pp 10854-10859, issn 0022-3263, 6 p.Article

Synthesis and self-assembly of amphiphilic diblock copolymers using a fluorescently labeled N-alkoxyamine initiatorTSIMELZON, Anna; DEAMER, David; BRASLAU, Rebecca et al.Macromolecular rapid communications. 2005, Vol 26, Num 23, pp 1872-1877, issn 1022-1336, 6 p.Article

Patterns of resistance and incomplete response to docetaxel by gene expression profiling in breast cancer patientsCHANG, Jenny C; WOOTEN, Eric C; CHAMNESS, Gary C et al.Journal of clinical oncology. 2005, Vol 23, Num 6, pp 1169-1177, issn 0732-183X, 9 p.Article

Wnt-1 is dominant over neu in specifying mammary tumor expression profilesSHIXIA HUANG; PODSYPANINA, Katrina; YIDONG CHEN et al.Technology in cancer research & treatment (Print). 2006, Vol 5, Num 6, pp 565-571, issn 1533-0346, 7 p.Article

Hazard rates of recurrence following diagnosis of primary breast cancerJATOI, Ismail; TSIMELZON, Anna; WEISS, Heidi et al.Breast cancer research and treatment. 2005, Vol 89, Num 2, pp 173-178, issn 0167-6806, 6 p.Article

Dicer-Mediated Upregulation of BCRP Confers Tamoxifen Resistance in Human Breast Cancer CellsSELEVER, Jennifer; GUOWEI GU; BOUMENDJEL, Ahcene et al.Clinical cancer research (Print). 2011, Vol 17, Num 20, pp 6510-6521, issn 1078-0432, 12 p.Article

Insulin-Like Growth Factor-I Activates Gene Transcription Programs Strongly Associated With Poor Breast Cancer PrognosisCREIGHTON, Chad J; CASA, Angelo; LAZARD, Zawaunyka et al.Journal of clinical oncology. 2008, Vol 26, Num 25, pp 4078-4085, issn 0732-183X, 8 p.Article

A phase II neoadjuvant trial of anastrozole, fulvestrant, and gefitinib in patients with newly diagnosed estrogen receptor positive breast cancerMASSARWEH, Suleiman; THAM, Yee L; FUQUA, Suzanne et al.Breast cancer research and treatment. 2011, Vol 129, Num 3, pp 819-827, issn 0167-6806, 9 p.Article

Loss of Rho GDIα and Resistance to Tamoxifen via Effects on Estrogen Receptor αBARONE, Ines; BRUSCO, Lauren; ANDO, Sebastiano et al.Journal of the National Cancer Institute. 2011, Vol 103, Num 7, pp 538-552, issn 0027-8874, 15 p.Article

Ductal Carcinoma In situ and the Emergence of Diversity during Breast Cancer Evolution. CommentaryPOLYAK, Kornelia; ALLRED, D. Craig; MEDINA, Dan et al.Clinical cancer research. 2008, Vol 14, Num 2, issn 1078-0432, 339-341, 370-378 [12 p.]Article

Growth of Triple-Negative Breast Cancer Cells Relies upon Coordinate Autocrine Expression of the Proinflammatory Cytokines IL-6 and IL-8HARTMAN, Zachary C; POAGE, Graham M; BROWN, Powel H et al.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 11, pp 3470-3480, issn 0008-5472, 11 p.Article

Estrogen and insulin-like growth factor-I (IGF-I) independently down-regulate critical repressors of breast cancer growthCASA, Angelo J; POTTER, Adam S; OESTERREICH, Steffi et al.Breast cancer research and treatment. 2012, Vol 132, Num 1, pp 61-73, issn 0167-6806, 13 p.Article

Development of Resistance to Targeted Therapies Transforms the Clinically Associated Molecular Profile Subtype of Breast Tumor XenograftsCREIGHTON, Chad J; MASSARWEH, Suleiman; SHIXIA HUANG et al.Cancer research (Chicago, Ill.). 2008, Vol 68, Num 18, pp 7493-7501, issn 0008-5472, 9 p.Article

Alterations of gene expression in the development of early hyperplastic precursors of breast cancerSANGJUN LEE; MEDINA, Dan; TSIMELZON, Anna et al.The American journal of pathology. 2007, Vol 171, Num 1, pp 252-262, issn 0002-9440, 11 p.Article

Molecular heterogeneity of inflammatory breast cancer : A hyperproliferative phenotypeNGUYEN, Dang M; SAM, Kathy; O'CONNELL, Peter et al.Clinical cancer research. 2006, Vol 12, Num 17, pp 5047-5054, issn 1078-0432, 8 p.Article

A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft ModelsXIAOMEI ZHANG; CLAERHOUT, Sofie; HELEN WONG et al.Cancer research (Chicago, Ill.). 2013, Vol 73, Num 15, pp 4885-4897, issn 0008-5472, 13 p.Article

High IGF-IR Activity in Triple-Negative Breast Cancer Cell Lines and Tumorgrafts Correlates with Sensitivity to Anti-IGF-IR TherapyLITZENBURGER, Beate C; CREIGHTON, Chad J; LEWIS, Michael T et al.Clinical cancer research (Print). 2011, Vol 17, Num 8, pp 2314-2327, issn 1078-0432, 14 p.Article

Tamoxifen Resistance in Breast Tumors Is Driven by Growth Factor Receptor Signaling with Repression of Classic Estrogen Receptor Genomic FunctionMASSARWEH, Suleiman; OSBORNE, C. Kent; CREIGHTON, Chad J et al.Cancer research (Baltimore). 2008, Vol 68, Num 3, pp 826-833, issn 0008-5472, 8 p.Article

Gene expression patterns for doxorubicin (Adriamycin) and cyclophosphamide (Cytoxan) (AC) response and resistanceCLEATOR, Susan; TSIMELZON, Anna; CHANG, Jenny C et al.Breast cancer research and treatment. 2006, Vol 95, Num 3, pp 229-233, issn 0167-6806, 5 p.Article

Gene expression profiling for the prediction of therapeutic response to docetaxel in patients with breast cancer. CommentaryCHANG, Jenny C; WOOTEN, Eric C; O'CONNELL, Peter et al.Lancet (British edition). 2003, Vol 362, Num 9381, pp 340-341, issn 0140-6736, 10 p.Article

Metastasis tumor-associated protein 2 enhances metastatic behavior and is associated with poor outcomes in estrogen receptor-negative breast cancerCOVINGTON, Kyle R; BRUSCO, Lauren; BARONE, Ines et al.Breast cancer research and treatment. 2013, Vol 141, Num 3, pp 375-384, issn 0167-6806, 10 p.Article

A gene transcription signature of obesity in breast cancerCREIGHTON, Chad J; SADA, Yvonne H; YIQUN ZHANG et al.Breast cancer research and treatment. 2012, Vol 132, Num 3, pp 993-1000, issn 0167-6806, 8 p.Article

Androgen receptor overexpression induces tamoxifen resistance in human breast cancer cellsDE AMICIS, Francesca; THIRUGNANSAMPANTHAN, Janagi; CHAMNESS, Gary C et al.Breast cancer research and treatment. 2010, Vol 121, Num 1, pp 1-11, issn 0167-6806, 11 p.Article

Decreased TGFβ signaling and increased COX2 expression in high risk women with increased mammographic breast densityWEI TSE YANG; LEWIS, Michael T; ARUN, Banu et al.Breast cancer research and treatment. 2010, Vol 119, Num 2, pp 305-314, issn 0167-6806, 10 p.Article

Identification of Novel Kinase Targets for the Treatment of Estrogen Receptor―Negative Breast CancerSPEERS, Corey; TSIMELZON, Anna; SEXTON, Krystal et al.Clinical cancer research (Print). 2009, Vol 15, Num 20, pp 6327-6340, issn 1078-0432, 14 p.Article

  • Page / 2